US Patent Issued to KYOTO UNIVERSITY, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY on Aug. 4 for "Pharmaceutical composition for treating autosomal dominant polycystic kidney disease" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,314, issued on Aug. 4, was assigned to KYOTO UNIVERSITY (Kyoto, Japan) and NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (Hokkaido, Japan).

"Pharmaceutical composition for treating autosomal dominant polycystic kidney disease" was invented by Kenji Osafune (Kyoto, Japan), Shinichi Mae (Kyoto, Japan), Saori Nishio (Sapporo, Japan), Fumihiko Hattanda (Sapporo, Japan), Tsuyoshi Nakano (Kyoto, Japan), Ryuichiro Hirayama (Kyoto, Japan), Tomoko Suzuki (Kyoto, Japan) and Ayuto Hayashi (Kyoto, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A new dosage regimen of a pharmaceutical composition comprising tamibarotene as the active ingredient for tr...